Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
As of 2025, retatrutide has not received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA) for routine clinical use in the UK
[6] It is a rare tumor type, with a relatively poor prognosis in children
Every cell in your body is encased in a protective fatty layer
The current standard of care involves regular intravenous infusions of FIX, often administered multiple times a week or multiple times a month, according to the company
US$ 27.00
US$ 29.80
US$ 29.39
US$ 22.52
